Procaps Group SA (PROC)
2.76
+0.14
(+5.34%)
USD |
NASDAQ |
May 31, 16:00
2.71
-0.05
(-1.81%)
After-Hours: 20:00
Procaps Group Cash from Financing (Quarterly): -29.88M for Sept. 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -29.88M |
| June 30, 2023 | -25.01M |
| March 31, 2023 | -18.59M |
| December 31, 2022 | 27.92M |
| September 30, 2022 | -5.36M |
| June 30, 2022 | -26.03M |
| March 31, 2022 | -10.16M |
| December 31, 2021 | -18.39M |
| Date | Value |
|---|---|
| September 30, 2021 | 67.64M |
| June 30, 2021 | 5.588M |
| March 31, 2021 | 3.199M |
| December 31, 2020 | -38.91M |
| September 30, 2020 | 4.559M |
| June 30, 2020 | -0.666M |
| March 31, 2020 | -5.496M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-38.91M
Minimum
Dec 2020
67.64M
Maximum
Sep 2021
-4.638M
Average
-5.496M
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| Alvotech | 133.18M |
| Moolec Science SA | 4.82M |
| Perspective Therapeutics Inc | 166.33M |
| Electromed Inc | 0.056M |
| Xtant Medical Holdings Inc | 5.179M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 47.39M |
| Cash from Investing (Quarterly) | -7.469M |
| Free Cash Flow | 34.06M |
| Free Cash Flow Per Share (Quarterly) | 0.3877 |
| Free Cash Flow to Equity (Quarterly) | 38.11M |
| Free Cash Flow to Firm (Quarterly) | 48.07M |
| Free Cash Flow Yield | 12.13% |